Lucid Diagnostics (LUCD) Cash & Equivalents Growth (1y) (2021 - 2026)
Lucid Diagnostics (LUCD) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 72.43% |
| 10 | Lucid Diagnostics | 176.51 Mn | 143.11 Mn | 55,000.00 | 7.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.33% |
| Mar 31, 2026 | 10.45% |
| Dec 31, 2025 | 55.22% |
| Sep 30, 2025 | 226.68% |
| Jun 30, 2025 | 24.89% |
| Mar 31, 2025 | 1.89% |
| Dec 31, 2024 | 18.32% |
| Sep 30, 2024 | -39.75% |
| Jun 30, 2024 | -23.49% |
| Mar 31, 2024 | -37.33% |
| Dec 31, 2023 | -15.92% |
| Sep 30, 2023 | -10.71% |
| Jun 30, 2023 | -0.33% |
| Mar 31, 2023 | -17.52% |
| Dec 31, 2022 | -58.11% |
| Sep 30, 2022 | 126,137.35% |
| Jun 30, 2022 | 1,364.77% |
| Mar 31, 2022 | 54,979.31% |
| Dec 31, 2021 | 48,238.74% |
| Sep 30, 2021 | -88.58% |